Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Achieve Life Sciences Inc (NQ: ACHV )

11.62 USD +0.20 (+1.75%)
Official Closing Price Updated: 6:13 PM EST, Mar 1, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 76,886
Open 11.77
Bid (Size) 11.40 (3)
Ask (Size) 11.62 (2)
Prev. Close 11.42
Today's Range 11.43 - 12.24
52wk Range 4.600 - 18.26
Shares Outstanding 2,764,276
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Achieve Life Sciences Announces Presentation of Data on Smoker and E-Cigarette User Attitudes and Perceptions on Quitting at the Society for Research on Nicotine & Tobacco (SRNT) Annual Meeting
From ACCESSWIRE
Achieve Life Sciences to Present at the MicroCap Rodeo Winter Wonderland Conference on February 16, 2021
From ACCESSWIRE

Performance

YTD
+47.09%
+47.09%
1 Month
-4.75%
-4.75%
3 Month
+34.80%
+34.80%
6 Month
+42.23%
+42.23%
1 Year
+9.62%
+9.62%

More News

Read More
Achieve Life Sciences to Present at H.C. Wainwright Virtual BioConnect Conference
From ACCESSWIRE
Achieve Life Sciences, Inc. Announces Closing of $17.3 Million Underwritten Public Offering, Including Full Exercise of Overallotment Option
From PR Newswire
Achieve Life Sciences Announces Pricing of $15 Million Public Offering
From PR Newswire
Achieve Life Sciences Announces Proposed Public Offering
From PR Newswire
Achieve Reports Financial Results for Third Quarter 2020 and Provides Corporate and Cytisinicline Development Update
From PR Newswire
Achieve Life Sciences to Announce Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 12, 2020
From PR Newswire
Achieve Life Sciences to Host Smoking Cessation Key Opinion Leader Virtual Roundtable on November 17th, 2020
From PR Newswire
Achieve Life Sciences Announces to Present at the MicroCap Best Ideas Conference, October 13, 2020
From ACCESSWIRE
Achieve Life Sciences Announces Start of Phase 3 ORCA-2 Clinical Trial Evaluating Cytisinicline for Smoking Cessation
From PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.